Workflow
Globenewswire
icon
Search documents
Black Rock Coffee Bar Files Registration Statement for Proposed Initial Public Offering
Globenewswire· 2025-08-18 16:50
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Black Rock Coffee Bar, Inc. (“Black Rock Coffee Bar”) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed offering is subject to market and other conditions, and there can be no assur ...
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
Globenewswire· 2025-08-18 16:45
CHICAGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today its financial results for the second quarter and six-month period ended June 30, 2025. Financial Highlights for the Three and Six Months Ended June 30, 2025 Income StatementCosmos Health continued its positive trajectory in Q2 2025, delivering double-digit revenue growth of 11.66% and a 51.60% increase in gross profit. ...
Sanofi: Information concerning the total number of voting rights and shares - July 2025
Globenewswire· 2025-08-18 16:30
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of €2,454,937,946Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Registry under nu ...
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
Globenewswire· 2025-08-18 16:30
Core Viewpoint - ONWARD Medical N.V. has received FDA approval for an investigational device exemption for its ARC-IM System, enabling the initiation of the Empower BP pivotal study to evaluate the safety and efficacy of its implantable spinal stimulation system for managing blood pressure instability after spinal cord injury (SCI) [2][7]. Group 1: Study Details - The Empower BP study is the second global pivotal study for ONWARD and the first to assess the ARC-IM System, involving approximately 20 leading neurorehabilitation and neurosurgical centers across the US, Canada, and Europe, with patient enrollment expected by year-end [3][7]. - The study will focus on participants with spinal cord injuries at levels C2-T6, with injury severities of AIS A-D, and those experiencing chronic orthostatic hypotension and episodes of autonomic dysreflexia [3]. Group 2: Market Need and Impact - Over 50% of individuals with SCI experience blood pressure instability, affecting nearly 350,000 people in the US and Europe, which can threaten neurological recovery and negatively impact cardiovascular health and quality of life [4][5]. - Addressing blood pressure instability is critical for improving long-term outcomes for SCI patients, as it is a significant but often unrecognized complication that can lead to increased cardiovascular disease risk [5][8]. Group 3: Technology Overview - The ARC-IM System is an implanted neuromodulation platform designed to deliver targeted spinal cord stimulation, specifically aimed at managing blood pressure instability in SCI patients [5][9]. - The system includes the ONWARD Neurostimulator and the ARC-IM Thoracic Lead, which is optimized for placement in the thoracic spinal cord's "Hemodynamic Hotspot," a location identified through research partnerships [5][6]. Group 4: Previous Results and Future Outlook - In December 2022, ONWARD announced positive interim clinical results from feasibility studies showing improved blood pressure regulation and hemodynamic stability after SCI, with participants reporting enhanced well-being and reduced symptoms of orthostatic hypotension [6]. - The FDA has awarded ONWARD one of its 10 Breakthrough Device Designations for the ARC-IM System, indicating its potential to address significant unmet medical needs and providing regulatory and reimbursement advantages [8].
Bocana Resources Corp. Schedules Due Diligence and Site Visit to Arizona Mining Claims
Globenewswire· 2025-08-18 16:16
Core Viewpoint - Bocana Resources Corp. is advancing its due diligence efforts by scheduling a site visit to the U.S. Bureau of Land Management placer mining claims in Arizona, owned by LP Associates, LLC, to gather essential information for operational development [1][4]. Group 1: Due Diligence Efforts - The company management and geologist will meet with key parties, including the seller, lead on-site geologist, mining consulting firms, legal representatives, and BLM officials, to ensure a thorough due diligence process [2]. - The objective includes verifying previously acquired assayed reports, understanding the permitting process, and strategizing with local engineering firms for optimal processing methods to maximize recovery of precious metals [2][3]. Group 2: Legal and Strategic Review - Bocana will review title documents related to property ownership and BLM Claims, as well as evaluate nearby Claims for potential strategic opportunities [3]. - The company will assess access to the Claims area via public roadways and examine existing conditions that may impact future development, such as restrictive covenants and environmental concerns [3]. Group 3: Company Background - Bocana Resources Corp. is focused on the acquisition, exploration, and development of mineral properties in North and South America, holding a 100% working interest in the Escala area concessions in Bolivia [5].
Rexel: Disclosure of trading in own shares from August 11 to August 15, 2025
Globenewswire· 2025-08-18 16:00
RELEASE DISCLOSURE OF TRADING IN OWN SHARES FROM AUGUST 11 TO AUGUST 15, 2025 In accordance with the authorization granted by the Shareholders’ Meeting in order to trade in own shares and pursuant to applicable law on share repurchases, Rexel declares the following purchases of its own shares from August 11 to August 15, 2025: Name of the issuerIdentity code of the issuer (Legal Entity Identifier)Day of transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily we ...
Marie Brizard Wine & Spirits Monthly declaration of the total number of voting rights and shares
Globenewswire· 2025-08-18 15:49
MONTHLY DECLARATION OF THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES (ARTICLE L233-8II THE COMMERCIAL CODE and 223-16 OF THE GENERAL REGULATIONS OF THE FINANCIAL MARKETS AUTHORITY (AMF)) Charenton-le-Pont, 18th August 2025 MARIE BRIZARD WINE & SPIRITS ISIN Code: 0000060873 Situation at:Total number of shares comprising share capitalTotal number of voting rights31 July 2025111 989 823Number of voting rights (1): 194 047 142Number of exercisable voting rights (2): 193 916 356 Do the Marie Brizard Wine & Spirit ...
VINCI awarded design and build contract in Australia
Globenewswire· 2025-08-18 15:45
Core Points - VINCI Construction subsidiary Seymour Whyte, in collaboration with John Holland, Jacobs, Mott MacDonald, and Major Road Projects Victoria, has secured a contract for a significant upgrade of the Eastern Freeway in Australia [2][5] - The total value of the construction contract is approximately 450 million euros (AUD 800 million), with an expected completion date by mid-2028 [2][5] Project Details - The upgrade will include the addition of one lane in each direction, a new dedicated busway, shared-use paths, various civil structures, and noise barriers to improve the living conditions for nearby residents [3]
Vaisala Corporation: Share Repurchase 18.8.2025
Globenewswire· 2025-08-18 15:30
Group 1 - Vaisala Corporation executed a share repurchase on August 18, 2025, buying 2,700 shares at an average price of €46.8344 per share, totaling €126,452.88 [1] - Following this transaction, Vaisala Corporation now holds a total of 140,084 shares [1] - The share buybacks are conducted in compliance with European regulations, specifically Regulation No. 596/2014 and Commission Delegated Regulation (EU) 2016/1052 [1] Group 2 - Vaisala is recognized as a global leader in measurement instruments and intelligence for climate action, focusing on improving resource efficiency and driving energy transition [2] - The company has nearly 90 years of innovation and expertise, employing around 2,500 experts dedicated to environmental measures [2] - Vaisala's series A shares are listed on the Nasdaq Helsinki stock exchange [2]
Roadzen Addresses Inaccurate Reporting of Analyst Expectations in Q1 FY2026 Results
Globenewswire· 2025-08-18 15:28
Recent media reports, originating from an AI-generated article on The Motley Fool and widely syndicated, misstated Roadzen’s analyst expectations as over $21 million in Q1 revenue, implying a revenue miss of more than 50%. Roadzen clarifies that these figures were never issued by its covering analysts, and that its record first quarter — the strongest Q1 in Company history — was in line with its operating plan and market estimates.NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roa ...